Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 951-959

  Tatarano, Shuichi ^a   Chiyomaru, Takeshi ^a   Kawakami, Kazumori ^a   Enokida, Hideki ^a   Yoshino, Hirofumi ^a   Hidaka, Hideo ^a   Nohata, Nijiro ^b   Yamasaki, Takeshi ^a   Gotanda, Takenari ^a   Tachiwada, Tokushi ^a   Seki, Naohiko ^b   Nakagawa, Masayuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; LUCIFERASE; MESODERM DEVELOPMENT CANDIDATE 1 PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 574 3P; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME 15Q; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; FLOW CYTOMETRY; GAIN OF FUNCTION MUTATION; GENE CONTROL; GENE FUNCTION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; MALE; MESODERM; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

AGED; APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MOLECULAR CHAPERONES; RNA, MESSENGER; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 84858643128     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1294     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Website of Center for Cancer Control and Information Services, National Cancer Center, Japan (http://ganjoho.jp/professional/statistics/statistics.html) .
3. Herr H, Konety B, Stein J, et al: Optimizing outcomes at every stage of bladder cancer: do we practice it? Urol Oncol 27: 72-74, 2009.
4. Zimmerman AL and Wu S: MicroRNAs, cancer and cancer stem cells. Cancer Lett 300: 10-19, 2011.
5. Fendler A, Stephan C, Yousef GM and Jung K: MicroRNAs as regulators of signal transduction in urological tumors. Clin Chem 57: 954-968, 2011.
6. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
7. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
8. Gottardo F, Liu CG, Ferracin M, et al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392, 2007. (Pubitemid 47362758)
9. Yang H, Dinney CP, Ye Y, et al: Evaluation of genetic variants in microRNA-related genes and high risk of bladder cancer. Cancer Res 68: 2530-2537, 2008. (Pubitemid 351521830)
10. Ichimi T, Enokida H, Okuno Y, et al: Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352, 2009.
11. Catto JW, Miah S, Owen HC, et al: Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 69: 8472-8481, 2009.
12. Catto JW, Alcaraz A, Bjartell AS, et al: MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59: 671-681, 2011.
13. Han Y, Chen J, Zhao X, et al: MicroRNA expression signature of bladder cancer revealed by deep sequencing. PLoS One 6: e18286, 2011.
14. Chiyomaru T, Enokida H, Tatarano S, et al: miR-145 and miR-133a function as tumor suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
15. Chiyomaru T, Enokida H, Kawakami K, et al: Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol 2010 [Epub ahead of print].
16. Yoshino H, Chiyomaru T, Enokida H, et al: The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818, 2011.
17. Tatarano S, Chiyomaru T, Kawakami K, et al: Mir-218 on the genomic loss region of chromosome 4p15.31 function as a tumor suppressor in bladder cancer. Int J Oncol 39: 13-21, 2011.
18. Matsuda R, Enokida H, Chiyomaru T, et al: LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling. Br J Cancer 104: 376-386, 2011.
19. Yoshitomi T, Kawakami K, Enokida H, et al: Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines. Oncol Rep 24: 1661-1668, 2011.
20. Takemoto M, Shirahama T, Miyauchi T, et al: Metanestin, a glycoprotein with metastasis-associated expression in transitional cell carcinoma of the urinary bladder. Int J Cancer 74: 7-14, 1997. (Pubitemid 27157848)
21. Sobin LH and Wittekind C: TNM Classification of Malignant Tumors. International Union Against Cancer (UICC). 6th edition. Wiley-Liss Publications, New York, NY, pp199-202, 2002.
22. Gui J, Tian Y, Wen X, et al: Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci 120: 183-193, 2011.
23. Hawkins SM, Creighton CJ, Han DY, et al: Functional microRNA involved in endometriosis. Mol Endocrinol 25: 821-832, 2011.
24. Chiyomaru T, Tatarano S, Kawakami K, et al: SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer. Prostate doi: 10.1002/pros.21372, 2011.
25. Kureishy N, Sapountzi V, Prag S, Anilkumar N and Adams JC: Fascins, and their roles in cell structure and function. Bioessays 24: 350-361, 2002. (Pubitemid 34305690)
26. Wines ME, Lee L, Katari MS, et al: Identification of mesoderm development (mesd) candidate genes by comparative mapping and genome sequence analysis. Genomics 72: 88-98, 2001. (Pubitemid 32225183)
27. Gingras AR, Bate N, Goult BT, et al: Central region of talin has a unique fold that binds vinculin and actin. J Biol Chem 285: 29577-29587, 2010.
28. Uchida Y, Chiyomaru T, Enokida H, et al: MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol 2011 [Epub ahead of print].
29. Nohata N, Hanazawa T, Kikkawa N, et al: Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 56: 595-601, 2011.
30. Kawakami K, Enokida H, Chiyomaru T, et al: The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 2011 [Epub ahead of print].
31. Nohata N, Hanazawa T, Kikkawa N, et al: Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol 39: 1099-1107, 2011.